Year: 2016
Type: dissertation
Abstract: Cell fate decisions during embryogenesis and in proliferation and regeneration competent adult tissues and organs are orchestrated by large numbers of regulators including transcription factors, non-coding RNAs, epigenetic modifiers and longer-range genomic interactions, each downstream of extrinsic signals and their intracellular signal transduction effector proteins. Zeb2 is a DNA-binding transcription factor that steers in such context many cellular processes during early and late embryogenesis, and knowledge is emerging about its role in various adult tissues/organs as well, especially in challenge conditions like tissue organ failure. Mutations in one allele of ZEB2 in humans cause Mowat-Wilson syndrome (MOWS) characterized by severe intellectual disability and, varying from patient to patient, epilepsy, Hirschsprung disease and other defects. In the mouse Zeb2 has been show, including by our laboratory, to regulate different aspects of central and peripheral nervous system (CNS, PNS, respectively) development as well as their post-natal functions. The same applies to embryonic and adult hematopoiesis, T-cell lineage development and function, and e.g. myelinogenesis in the CNS and (re)myelination by Schwann cells in the PNS. In addition, deregulation of the levels of Zeb2, e.g.. an abnormal increase, contributes (in this case) to many cancers and correlates with bad prognosis in humans, as supported by Zeb2 overexpression mouse models. The action mechanisms by which Zeb2, in concert with many of its emerging protein partners, steers neurogenesis and gliogenesis can be studied in cultured embryonic stem cells (ESCs) and the early CNS in vivo. In human ESCs, intact levels of ZEB2 were shown to be essential for effective neuroectoderm differentiation. The goals of this PhD project were to understand where, when and how Zeb2 functions (i) during mouse brain cortex development (using an in vivo approach) and (ii) in pluripotency and subsequent differentiation of mouse ESCs (in vitro approach). Genetic inactivation of both alleles of Zeb2 in early neural progenitors (using a Nestin-Cre approach), from dorsal telencephalon (Emx1-Cre) as well as in post-mitotic (NEX-Cre) upper layer neurons in the forming cortex in the embryonic forebrain causes a shift forward in the timing of first embryonic neurogenesis followed by embryonic and early post-natal gliogenesis. This leads to the expansion of the upper layers of the cortex at the expense of the (earlier born) cells of the deeper layers. Using gene expression profiling followed by validation, which is an essential part of this work and this PhD project, we identified neurotrophin-3 (Nt3) and fibroblast growth factor-9 (Fgf9) as extrinsic factors whose levels were significantly increased in the upper layer cells of the Zeb2 knockout (KO) embryonic brain cortex as compared to control. In this way, Zeb2 regulates the generation of subsequent waves of neurogenesis (steered by Nt3 that acts on its Trk receptor complex in the progenitor cells and promotes neurogenesis) and of gliogenesis (via Fgf9 that acts on its receptors there) emanating from the Zeb2-negative progenitor cells in the cortex. Importantly, this work identified Zeb2 as the first transcription factor acting in a cell non-autonomous fashion in cortex development. In the second part of this PhD research the focus was on the role(s) and action mechanism(s) of Zeb2 in pluripotency and during differentiation of ESCs. For this, Zeb2-deficient (KO) ESCs were established. Using these novel, unique tools in combination with omics, this PhD project was able to add important new functional and mechanistic insight to previous findings. We discovered that Zeb2 is critical for exit from the epiblast state in mouse ESCs and links the pluripotency network and DNA-methylation with irreversible commitment to neural and general differentiation. In particular, we show that Zeb2 KO ESCs display impaired differentiation in embryoid bodies by stalling in an epiblast-like state. Using RNA-Seq we further conclude that Zeb2 mainly acts here as a transcriptional repressor for many genes, either directly or indirectly, in differentiating conditions. Epithelial-mesenchymal transition (EMT), pluripotency, lineage commitment and DNA-(de)methylation genes are deregulated in Zeb2 KO embryoid bodies. By using methylome analysis, we demonstrate these mutant cells cannot maintain their initially acquired DNA-methylation marks in neural-stimulating condition and do not effectively downregulate Oct4, Nanog and Tet1 in differentiation conditions. Tet1 knockdown by RNA interference partially rescues the impaired differentiation of these KO cells. Another part of the PhD project investigated, starting again from the RNA-Seq data, the neuronal inhibitory REST gene, one of the genes whose expression was not silenced in Zeb2 KO ESCs, unlike in normal ESCs. Like for the Tet1 studies, stable REST knockdown lines were established in the Zeb2 KO background. The neural differentiation capacity of such cells line was also partially restored, indicating that REST is another important Zeb2-dependent gene in ESCs. In a last set of experiments, which provide the strong basis for future structure-function analysis of Zeb2 (and hence insight into its functional domains) in this ESC system, the neurodevelopmental potential of Zeb2 Smad-binding domain (SBD) mutant cells was documented. We observed that deletion of the SBD from Zeb2 had a positive effect on neural differentiation, indicating that this Zeb2 domain, and hence possibly its interaction with Smads, co-determines Zeb2’s neural-inducing activity.
Source: Lirias (KU Leuven)
Author: Stryjewska, Agata
Institution: KU Leuven
Language: English
Subfield: Developmental Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7009015955
